Takuro Uchida Selected Research

Takuro Uchida Research Topics

Disease

21	Infections 02/2022 - 01/2015
9	Chronic Hepatitis B 01/2019 - 01/2016
7	Chronic Hepatitis C 01/2021 - 02/2016
4	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 01/2018
4	Hepatitis B 01/2021 - 10/2015
3	Hepatitis 01/2021 - 12/2018
2	Inflammation (Inflammations) 01/2022 - 07/2019
2	Disease Progression 12/2021 - 07/2019
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 12/2018
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2017 - 01/2017
1	Ulcerative Colitis 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Coinfection 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Necrosis 01/2018
1	Diarrhea 01/2018
1	Neoplasms (Cancer) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2016
1	Edema (Dropsy) 08/2016
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2015

Drug/Important Bio-Agent (IBA)

13	Antiviral Agents (Antivirals)IBA 02/2022 - 09/2015
6	InterferonsIBA 01/2019 - 09/2015
5	daclatasvirIBA 01/2020 - 01/2015
5	asunaprevirIBA 01/2020 - 01/2015
5	AntigensIBA 01/2019 - 10/2015
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 10/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2018
3	NucleotidesIBA 01/2019 - 01/2018
3	NucleosidesIBA 01/2019 - 01/2018
2	CytokinesIBA 07/2019 - 01/2018
2	ChemokinesIBA 07/2019 - 01/2018
2	entecavir FDA Link 12/2018 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 01/2018
2	HMGB1 Protein (HMG1)IBA 01/2018 - 01/2018
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2017 - 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 06/2022
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2022
1	lenvatinibIBA 01/2022
1	FlagellinIBA 01/2022
1	SodiumIBA 12/2021
1	Peptides (Polypeptides)IBA 12/2021
1	Taurocholic Acid (Sodium Taurocholate)IBA 12/2021
1	Abatacept (Orencia)FDA Link 01/2021
1	GlucocorticoidsIBA 01/2021
1	glecaprevir and pibrentasvirIBA 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2021
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	IntegrinsIBA 07/2019
1	glecaprevirIBA 03/2019
1	pibrentasvirIBA 03/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 12/2018
1	LuciferasesIBA 01/2018
1	Hepatitis B e AntigensIBA 01/2018
1	Fetal Proteins (Fetoprotein)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 01/2018
1	chlorcyclizineIBA 01/2018
1	Complementary DNA (cDNA)IBA 05/2017
1	Interferon-betaIBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2016
1	SimeprevirIBA 12/2016
1	VaccinesIBA 11/2016
1	CreatinineIBA 08/2016
1	Tenofovir (Viread)FDA Link 01/2016
1	Interferon LambdaIBA 09/2015

Therapy/Procedure

16	Therapeutics 06/2022 - 01/2015
3	Drug Therapy (Chemotherapy) 06/2022 - 01/2018
2	Liver Transplantation 01/2021 - 10/2015
1	Complementary Therapies (Alternative Medicine) 01/2021